Tilaknagar Industries Limited (TI) Q1 Results FY27 Preview: Date, Time, Expectations & Key Things To Watch

CompoundingAI Research Updated July 23, 2026 3 min read

Tilaknagar Industries is navigating a transformative period as it integrates the Imperial Blue whisky business while managing record-breaking sales volumes. Investors will be focused on the company's ability to balance margin-pressuring input costs with the operational efficiencies gained from its expanded in-house bottling capacity.

Quick Details
Results dateJuly 27, 2026
QuarterQ1 FY 2026-2027
Previous quarter revenueRs. 949 Cr
Previous quarter PATRs. (15) Cr
Previous quarter EBITDA margin16.3%
Net debt (latest quarter)Rs. 1,934 Cr
Market capRs. 10,919.77 Cr
CMPRs. 441.25

Tilaknagar Industries Limited Q1 Results Date and Time

The board meeting is scheduled for July 27, 2026, to consider the Q1 FY27 unaudited financial results.

What to expect from Tilaknagar Industries Limited's Q1 FY27 results

The company enters Q1 FY27 with significant volume momentum, reporting record sales of 3.4 million cases in June 2026 and over 3 million cases in May 2026. While demand remains strong, management faces a material input cost headwind from a 15–20% surge in glass bottle prices that emerged during the quarter. To offset these pressures, the firm is leveraging the recent 6x capacity expansion at the Prag Distillery, which is expected to yield annual bottling savings of Rs. 10 crore. Furthermore, the Karnataka government's implementation of a Rs. 20 MRP reduction on 180ml packs of Imperial Blue and Mansion House is expected to drive volume growth, consistent with historical precedents of similar price cuts. The upcoming call will likely focus on the TSMA expense run-rate, which was approximately Rs. 14 crore per month in Q4 FY26, and the pace of deleveraging toward the Rs. 1,700 crore net debt target set for March 2027.

Key Things To Watch

Performance vs Guidance Tracking

  • Combined business volume growth: high-single digit to low-double digit for FY27 — Q1 FY27 is the first tracking period
  • Combined business EBITDA margin: 16-18% by FY29 — watch for sequential improvement from the 15.5% adjusted margin in Q4 FY26
  • Net debt: target of Rs. 1,700 crore by March 2027 — monitor Q1 movement from the Rs. 1,934 crore base
  • Prag expansion savings: Rs. 10 crore per annum — check for materialization of benefits in Q1

IB Integration and Operational Focus

  • TSMA exit status for the remaining 3 states and the associated expense run-rate
  • Impact of the Karnataka MRP reduction on Q1 volume uplift for Imperial Blue and Mansion House
  • Update on the House of TI premium portfolio sales in West Bengal and Spaceman Spirits Lab distribution ramp-up

Risks and Headwinds to Monitor

  • Management response to the 15–20% surge in glass bottle prices and pass-through mechanisms
  • Resolution status of the qualified audit opinion regarding the ENA plant impairment assessment
  • Finance cost trajectory given the Rs. 68.91 crore expense recorded in Q4 FY26

Frequently Asked Questions

How is the company progressing with the Imperial Blue business integration?

As of the start of Q1 FY27, Tilaknagar Industries has exited the Transition Services and Manufacturing Agreement (TSMA) for approximately 75% of the Imperial Blue business. The company aims to complete the exit for the remaining states no later than Q4 FY27.

What is the expected impact of the Prag Distillery expansion?

The expansion at the Prag Distillery increased capacity from 6 lakh to 36 lakh cases per annum. This investment is expected to generate annual savings of Rs. 10 crore in bottling costs.

Why did the company's finance costs increase significantly in FY26?

Finance costs rose to Rs. 113 crore in FY26 compared to Rs. 12 crore in FY25, primarily due to debt taken on for the Imperial Blue acquisition. In Q4 FY26 alone, finance costs reached Rs. 69 crore.

Powered by CompoundingAI — AI research platform for Indian stocks, every claim cited from primary filings

Login Now